In a series of memos last week, Center for Biologics Evaluation and Research Director Vinay Prasad outlined the FDA’s thinking on the recent limited approvals for updated COVID-19 vaccines.
Prasad Signals Steeper Requirements for COVID-19 Vaccines Read More »
ACOs are also improving in quality, according to the CMS data. Still, the Medicare Shared Savings Program has struggled with waning provider buy-in.
Medicare saved record $2.4B from largest accountable care program last year Read More »
Novartis and Argo Biopharma go back to January 2024, when the pharma first bet up to $4.165 billion across two RNAi agreements targeting cardiovascular diseases.
Novartis Doubles Down on Argo Pact With Fresh $5.2B Commitment Read More »
Aside from lowering triglyceride levels, Ionis’ olezarsen reduced acute pancreatitis events, an outcome that BMO Capital Markets said could help the asset deliver a “significant first-in-class commercial launch.”
Ionis’ Tryngolza Hits ‘Best-Case Scenario’ in Late-Stage Triglyceride Study Read More »
Data from the late-stage MAPLE-HCM study position Cytokinetics’ cardiac myosin inhibitor aficamten as a potential first-line therapy for patients with obstructive hypertrophic cardiomyopathy.
Cytokinetics Soars on Aficamten’s ‘Best-in-Class’ Performance in Phase III Cardio Study Read More »
Health Secretary Robert F. Kennedy Jr. will appear before the Senate Finance Committee Thursday, ahead of a vaccine advisory committee meeting later in September. Meanwhile, deal-making appetite appears healthy, and the weight loss space continues generating clinical data and other news.
La investigación en la que se ha realizado este experimento muestra por primera vez que dos núcleos atómicos casi iguales (imagen especular uno del otro), se comportan de forma diferente en contra de un modelo vigente desde principios del siglo XX. Concretamente, este asombroso …
Un experimento desafía uno de los principios de la física nuclear Read More »
Un mayor bienestar puede ayudar a reducir el riesgo de pérdida de memoria en la mediana edad, según un nuevo estudio basado en un seguimiento de más de diez mil personas de más de cincuenta años durante un periodo de dieciséis años. En esta i …
Data scientist employment is expected to grow 33.5% from 2024 to 2034 due in part to a growing demand for data analysis, according to new U.S. Bureau Labor of Statistics findings. Biopharma hotspots were among the top 10 states for employment and pay for this role in 2024.
Data Scientist Fourth Fastest-Growing U.S. Job, Says BLS Read More »
En la búsqueda de fuentes limpias y sostenibles de energía, hay científicos trabajando en el desarrollo de generadores termoeléctricos solares como una fuente prometedora de generación de electricidad solar. A diferencia de la energía fotovoltaica utilizada …
Generador termoeléctrico solar 15 veces más eficiente que los mejores de hoy en día Read More »
